Assignee
ANDRX CORP
US·7 granted patents·8 pending applications·417 citations·filing 1998–2007
Top patents by PatentIndex Score
15 records- 0196US6720003B2Serotonin reuptake inhibitor formulationsANDRX CORP·Filed 2001·Granted Apr 13, 2004·77 cites·46 claims
- 0295US6544556B1Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitorANDRX CORP·Filed 2000·Granted Apr 8, 2003·86 cites·34 claims
- 0393US6099862AOral dosage form for the controlled release of a biguanide and sulfonylureaANDRX CORP·Filed 1998·Granted Aug 8, 2000·124 cites·4 claims
- 0490US6683112B2Gabapentin prodrugs and formulationsANDRX CORP·Filed 2001·Granted Jan 27, 2004·26 cites·10 claims
- 0589US6610326B2Divalproex sodium tabletsANDRX CORP·Filed 2001·Granted Aug 26, 2003·25 cites·56 claims
- 0687US6106862AOnce daily analgesic tabletANDRX CORP·Filed 1998·Granted Aug 22, 2000·78 cites·16 claims
- 0766US2006008526A1Controlled release metformin compositionsANDRX CORP·Filed 2005·Application pending·0 cites
- 0866US2006008525A1Controlled release metformin compositionsANDRX CORP·Filed 2005·Application pending·0 cites
- 0966US2006008523A1Controlled release metformin compositionsANDRX CORP·Filed 2005·Application pending·0 cites
- 1066US2006008524A1Controlled release metformin compositionsANDRX CORP·Filed 2005·Application pending·0 cites
- 1164US7713550B2Controlled release sodium valproate formulationANDRX CORP·Filed 2004·Granted May 11, 2010·1 cites·3 claims
- 1264US2007160671A1Biguanide formulationsANDRX CORP·Filed 2007·Application pending·0 cites
- 1360US2005027011A1Serotonin reuptake inhibitor formulationsANDRX CORP·Filed 2003·Application pending·0 cites
- 1457US2007184078A1Packaging systemANDRX CORP·Filed 2007·Application pending·0 cites
- 1551US2001024659A1Controlled release metformin formulationsANDRX CORP·Filed 2000·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →